We are live on
!
Find out more
Clearstead Advisors Portfolio holdings
AUM
$10.6B
Turnover
42.91%
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+14.75%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
-$353M
(-3.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
28.93%
Holding
3,754
New
1,518
Increased
1,198
Reduced
637
Closed
93
Avg Time Held Equity + Options
2
years
Top 10 Avg Time Held Equity + Options
3
years
Top 20 Avg Time Held Equity + Options
3
years
Avg Time Held Equity only
2
years
Top 10 Avg Time Held Equity only
3
years
Top 20 Avg Time Held Equity only
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.46% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
Boston Omaha
BOC
$384M
| $164 | ﹤0.01% |
+12
| New | +$151 |
2026 Q2
0 quarters
|
|
3252
Primis Financial Corp
FRST
$383M
| $164 | ﹤0.01% |
+10
| New | +$146 |
2026 Q2
0 quarters
|
|
3253
MiNK Therapeutics
INKT
$50.7M
| $164 | ﹤0.01% |
14
| – | – |
2025 Q1
5 quarters
|
|
3254
Via Transportation Inc
VIA
$2.74B
| $164 | ﹤0.01% |
+9
| New | +$141 |
2026 Q2
0 quarters
|
|
3255
ATN International
ATNI
$398M
| $159 | ﹤0.01% |
+6
| New | +$163 |
2026 Q2
0 quarters
|
|
3256
DELISTED
Stellar Bancorp
STEL
| $158 | ﹤0.01% |
+4
| New | +$151 |
2026 Q2
0 quarters
|
|
3257
Weis Markets
WMK
$1.87B
| $158 | ﹤0.01% |
+2
| New | +$147 |
2026 Q2
0 quarters
|
|
3258
Optimum Communications Inc
OPTU
$366M
| $157 | ﹤0.01% |
+108
| New | +$134 |
2026 Q2
0 quarters
|
|
3259
Concrete Pumping Holdings
BBCP
$460M
| $157 | ﹤0.01% |
+13
| New | +$112 |
2026 Q2
0 quarters
|
|
3260
Zymeworks
ZYME
$1.85B
| $157 | ﹤0.01% |
+6
| New | +$152 |
2026 Q2
0 quarters
|
|
3261
Aviat Networks
AVNW
$250M
| $156 | ﹤0.01% |
+7
| New | +$137 |
2026 Q2
0 quarters
|
|
3262
Hagerty
HGTY
$1.7B
| $156 | ﹤0.01% |
+13
| New | +$139 |
2026 Q2
0 quarters
|
|
3263
Power Solutions International
PSIX
$1.17B
| $156 | ﹤0.01% |
4
| – | – |
2025 Q3
3 quarters
|
|
3264
Gladstone Land Corp
LAND
$404M
| $155 | ﹤0.01% |
+18
| New | +$172 |
2026 Q2
0 quarters
|
|
3265
Miller Industries
MLR
$582M
| $155 | ﹤0.01% |
+3
| New | +$144 |
2026 Q2
0 quarters
|
|
3266
Arcus Biosciences
RCUS
$2.91B
| $155 | ﹤0.01% |
+5
| New | +$124 |
2026 Q2
0 quarters
|
|
3267
Intellia Therapeutics
NTLA
$1.59B
| $153 | ﹤0.01% |
+9
| New | +$126 |
2026 Q2
0 quarters
|
|
3268
Arbor Realty Trust
ABR
$522M
| $152 | ﹤0.01% |
+28
| New | +$182 |
2026 Q2
0 quarters
|
|
3269
Donegal Group Class A
DGICA
$687M
| $151 | ﹤0.01% |
+8
| New | +$139 |
2026 Q2
0 quarters
|
|
3270
Merchants Bancorp
MBIN
$2.25B
| $150 | ﹤0.01% |
+3
| New | +$142 |
2026 Q2
0 quarters
|
|
3271
Bicara Therapeutics
BCAX
$1.17B
| $149 | ﹤0.01% |
+5
| New | +$112 |
2026 Q2
0 quarters
|
|
3272
Atrium Therapeutics
RNA
$134M
| $149 | ﹤0.01% |
+11
| New | +$144 |
2026 Q2
0 quarters
|
|
3273
Avis
CAR
$3.88B
| $148 | ﹤0.01% |
1
-9
| -90% | -$1.98K |
2025 Q2
4 quarters
|
|
3274
ChargePoint
CHPT
$194M
| $148 | ﹤0.01% |
25
| – | – |
2021 Q1
21 quarters
|
|
3275
Disc Medicine
IRON
$2.17B
| $148 | ﹤0.01% |
+2
| New | +$137 |
2026 Q2
0 quarters
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,518 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,518 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.